Annex Advisory Services LLC lessened its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 14.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,316 shares of the pharmacy operator’s stock after selling 897 shares during the quarter. Annex Advisory Services LLC’s holdings in Walgreens Boots Alliance were worth $410,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in WBA. Vanguard Group Inc. lifted its stake in shares of Walgreens Boots Alliance by 2.8% in the 2nd quarter. Vanguard Group Inc. now owns 69,985,653 shares of the pharmacy operator’s stock valued at $5,480,577,000 after purchasing an additional 1,926,108 shares during the last quarter. Wellington Management Group LLP lifted its stake in shares of Walgreens Boots Alliance by 5.9% in the 1st quarter. Wellington Management Group LLP now owns 32,846,862 shares of the pharmacy operator’s stock valued at $2,727,932,000 after purchasing an additional 1,824,300 shares during the last quarter. Franklin Resources Inc. lifted its stake in shares of Walgreens Boots Alliance by 24.7% in the 2nd quarter. Franklin Resources Inc. now owns 18,502,701 shares of the pharmacy operator’s stock valued at $1,448,939,000 after purchasing an additional 3,662,302 shares during the last quarter. Nordea Investment Management AB lifted its stake in shares of Walgreens Boots Alliance by 10.2% in the 2nd quarter. Nordea Investment Management AB now owns 10,085,836 shares of the pharmacy operator’s stock valued at $789,822,000 after purchasing an additional 931,508 shares during the last quarter. Finally, CI Global Investments Inc. lifted its stake in shares of Walgreens Boots Alliance by 4.8% in the 2nd quarter. CI Global Investments Inc. now owns 5,931,592 shares of the pharmacy operator’s stock valued at $464,503,000 after purchasing an additional 270,182 shares during the last quarter. Institutional investors and hedge funds own 61.18% of the company’s stock.

Several equities research analysts have recently issued reports on WBA shares. Jefferies Group reaffirmed a “buy” rating and issued a $95.00 price objective on shares of Walgreens Boots Alliance in a research note on Monday, October 2nd. Needham & Company LLC reaffirmed a “buy” rating and issued a $94.00 price objective on shares of Walgreens Boots Alliance in a research note on Saturday, September 16th. Loop Capital started coverage on Walgreens Boots Alliance in a research note on Thursday, August 24th. They issued a “buy” rating and a $95.00 price objective for the company. UBS reaffirmed a “buy” rating and issued a $96.00 price objective (down from $97.00) on shares of Walgreens Boots Alliance in a research note on Wednesday, August 23rd. Finally, Mizuho set a $94.00 price objective on Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Tuesday, October 24th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $86.47.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the transaction, the director now directly owns 16,415 shares in the company, valued at approximately $1,105,878.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director John Anthony Lederer acquired 20,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, October 26th. The shares were purchased at an average price of $67.00 per share, for a total transaction of $1,340,000.00. Following the completion of the acquisition, the director now directly owns 50,000 shares in the company, valued at $3,350,000. The disclosure for this purchase can be found here. Company insiders own 14.80% of the company’s stock.

Walgreens Boots Alliance Inc (WBA) opened at $72.72 on Thursday. The company has a market capitalization of $71,850.31, a price-to-earnings ratio of 14.23, a price-to-earnings-growth ratio of 1.29 and a beta of 1.22. Walgreens Boots Alliance Inc has a fifty-two week low of $63.82 and a fifty-two week high of $88.00. The company has a current ratio of 1.07, a quick ratio of 0.59 and a debt-to-equity ratio of 0.45.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Wednesday, October 25th. The pharmacy operator reported $1.31 EPS for the quarter, topping the consensus estimate of $1.21 by $0.10. The company had revenue of $30.15 billion for the quarter, compared to the consensus estimate of $29.93 billion. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. Walgreens Boots Alliance’s quarterly revenue was up 5.3% on a year-over-year basis. During the same period last year, the business posted $1.07 EPS. equities analysts predict that Walgreens Boots Alliance Inc will post 5.54 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Monday, November 13th were issued a dividend of $0.40 per share. The ex-dividend date was Friday, November 10th. This represents a $1.60 annualized dividend and a yield of 2.20%. Walgreens Boots Alliance’s payout ratio is currently 42.33%.

Walgreens Boots Alliance declared that its board has approved a stock repurchase program on Wednesday, October 25th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the pharmacy operator to purchase shares of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s leadership believes its stock is undervalued.

WARNING: This story was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this story on another domain, it was stolen and reposted in violation of United States and international trademark and copyright laws. The original version of this story can be accessed at https://www.watchlistnews.com/walgreens-boots-alliance-inc-wba-shares-sold-by-annex-advisory-services-llc/1775664.html.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.